Health

Sanofi Launches Inhaled Insulin for Diabetics

  (CNBC) – Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life. Developed by Mannkind, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Read More

Advertisements
Health

For Diabetics, a New Insulin Inhaler Could Replace Shots as Early as 2014

[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed positive results for controlling diabetes in a late-stage clinical trial, the drug’s maker, MannKind (MNKD), reported today. Pharmaceutical companies have been Read More